UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

The lancet. Diabetes & endocrinology, 2017-12, Vol.5 (12), p.941-950

2017

Volltextzugriff (PDF)

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

The Lancet (British edition), 2009-05, Vol.373 (9677), p.1780-1788

2009

Volltextzugriff (PDF)

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

BMJ open, 2019-04, Vol.9 (4), p.e025580-e025580

2019

Volltextzugriff (PDF)

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Diabetes care, 2014-08, Vol.37 (8), p.2351-2358

2014

Volltextzugriff (PDF)

Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register

Diabetes care, 2020-09, Vol.43 (9), p.2257-2265

2020

Volltextzugriff (PDF)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Scientific reports, 2021-09, Vol.11 (1), p.18708-18708, Article 18708

2021

Volltextzugriff (PDF)

Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes

The journal of clinical endocrinology and metabolism, 2012-12, Vol.97 (12), p.4701-4708

2012

Volltextzugriff (PDF)

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

PLoS medicine, 2009-09, Vol.6 (9), p.e1000154

2009

Volltextzugriff (PDF)

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study

Clinical chemistry (Baltimore, Md.), 2017-07, Vol.63 (7), p.1261-1270

2017

Volltextzugriff (PDF)

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

Trials, 2019-06, Vol.20 (1), p.366-366, Article 366

2019

Volltextzugriff (PDF)

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Metabolism, clinical and experimental, 2016-05, Vol.65 (5), p.783-793

2016

Volltextzugriff (PDF)

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

Diabetes care, 2012-05, Vol.35 (5), p.1165-1170

2012

Volltextzugriff (PDF)

Using the EQ-5D Index Score as a Predictor of Outcomes in Patients with Type 2 Diabetes

Medical care, 2009-01, Vol.47 (1), p.61-68

2009

Volltextzugriff (PDF)

Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy

Diabetes research and clinical practice, 2014-11, Vol.106 (2), p.328-336

2014

Volltextzugriff (PDF)

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Circulation (New York, N.Y.), 2019-03, Vol.139 (12), p.1483-1492

2019

Volltextzugriff (PDF)

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

The Lancet (British edition), 2019-02, Vol.393 (10170), p.407-415

2019

Volltextzugriff (PDF)

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

The lancet. Diabetes & endocrinology, 2021-01, Vol.9 (1), p.32-45

2021

Volltextzugriff (PDF)

LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial

European journal of preventive cardiology, 2021-07, Vol.28 (8), p.805-812

2021

Volltextzugriff (PDF)

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

The lancet. Diabetes & endocrinology, 2016-10, Vol.4 (10), p.829-839

2016

Volltextzugriff (PDF)

Subgroup analysis: application to individual patient decisions

Medical journal of Australia, 2004-05, Vol.180 (9), p.467-469

2004

Volltextzugriff (PDF)

First-Line First? Trends in Thiazide Prescribing for Hypertensive Seniors

PLoS medicine, 2005-04, Vol.2 (4), p.e80-e80, Article e80

2005

Volltextzugriff (PDF)

Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.772-780

2019

Volltextzugriff (PDF)

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: Results from the LIPID trial

Diabetes care, 2003-10, Vol.26 (10), p.2713-2721

2003

Volltextzugriff (PDF)

An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes

Diabetes technology & therapeutics, 2023-02, Vol.25 (2), p.108-115

2023

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe New England Journal Of Medicine

ThemaCardiovascular Disease

ThemaCardiovascular System & Cardiology

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Male
(32)
Female
(28)
Middle Aged
(28)
Endocrinology & Metabolism
(16)
Diabetes
(14)
Adult
(12)
Diabetes Mellitus, Type 2 - Drug Therapy
(12)
Treatment Outcome
(12)
Risk Factors
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Double-Blind Method
(9)
Fenofibrate - Therapeutic Use
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Diabetes Mellitus
(8)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes Care
(4)
The Lancet
(4)
The Lancet. Diabetes & Endocrinology
(4)
Lancet
(3)
Plos Medicine
(2)
The lancet. Diabetes & Endocrinology
(2)
Bmj Open
(1)
Circulation
(1)
Clinical Chemistry
(1)
Clinical Endocrinology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Relative leucocyte telomere length is associated with incident end-stage kidney disease and rapid decline of kidney function in type 2 diabetes: analysis from the Hong Kong Diabetes Register

Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study

Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

Using the EQ-5D Index Score as a Predictor of Outcomes in Patients with Type 2 Diabetes

Cigarette smoking and albuminuria are associated with impaired arterial smooth muscle function in patients with type 2 diabetes mellitus: a FIELD substudy

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials

Subgroup analysis: application to individual patient decisions

First-Line First? Trends in Thiazide Prescribing for Hypertensive Seniors

Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: Results from the LIPID trial

An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes

Aktive Filter

Suchergebnisse filtern